• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基质靶向疗法可增强可移植大鼠前列腺癌模型中的去势效果。

A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.

作者信息

Johansson Anna, Jones Jonathan, Pietras Kristian, Kilter Sigrid, Skytt Asa, Rudolfsson Stina Häggström, Bergh Anders

机构信息

Department of Medical Bioscience, Pathology, Umeå University, Sweden.

出版信息

Prostate. 2007 Nov 1;67(15):1664-76. doi: 10.1002/pros.20657.

DOI:10.1002/pros.20657
PMID:17854058
Abstract

BACKGROUND

Castration results in a major involution of the normal prostate gland. This process is initiated by effects in the prostate stroma and vasculature. Castration-induced regression of androgen sensitive prostate tumors is however less prominent and hypothetically this could be related to a limited stromal/vascular response. We therefore used animal tumor models to explore the importance of stroma and vascular effects, and if castration effects could be enhanced by a simultaneous therapy targeting the tumor stroma.

METHODS

Using rats with Dunning PAP and H tumors, stereological methods, immunohistochemistry, and Western blotting, we studied the tumor response 7 and 28 days after castration and after the addition of stroma targeted therapies.

RESULTS

In the normal ventral prostate (VP) nuclear androgen receptors (AR) were rapidly downregulated after castration. In contrast, the Dunning tumors downregulated the AR in the cancerous epithelium, but not in the surrounding stroma. Vascular regulators such as the angiopoietins, tie 2, and PDGF-Rbeta were not decreased in the stroma after castration, as observed in the VP, creating an environment that prevents vascular involution. When a tumor stroma targeted therapy inhibiting the tie 2 receptor and the PDGF-Rbeta simultaneously was added to castration it resulted in a decreased vascular density, increased tumor cell apoptosis and decreased tumor growth compared to castration alone.

CONCLUSIONS

The stroma in highly differentiated androgen sensitive Dunning tumors is apparently androgen insensitive. If this unresponsive stroma is targeted the effects of castration can be enhanced.

摘要

背景

去势导致正常前列腺显著萎缩。这一过程由前列腺基质和脉管系统的变化引发。然而,去势诱导的雄激素敏感性前列腺肿瘤消退并不明显,据推测这可能与有限的基质/血管反应有关。因此,我们使用动物肿瘤模型来探究基质和血管效应的重要性,以及去势效应是否可通过同时靶向肿瘤基质的治疗得以增强。

方法

利用患有邓宁PAP和H肿瘤的大鼠,采用体视学方法、免疫组织化学和蛋白质印迹法,我们研究了去势后以及添加基质靶向治疗7天和28天后的肿瘤反应。

结果

在正常腹侧前列腺(VP)中,去势后核雄激素受体(AR)迅速下调。相比之下,邓宁肿瘤在癌上皮细胞中下调了AR,但在周围基质中未下调。与VP中观察到的情况不同,去势后基质中的血管调节因子如血管生成素、酪氨酸激酶2(Tie 2)和血小板衍生生长因子受体β(PDGF-Rβ)并未减少,从而形成了一个阻止血管萎缩的环境。当在去势治疗的同时添加一种同时抑制Tie 2受体和PDGF-Rβ的肿瘤基质靶向治疗时,与单纯去势相比,其导致血管密度降低、肿瘤细胞凋亡增加以及肿瘤生长减缓。

结论

高分化雄激素敏感性邓宁肿瘤中的基质显然对雄激素不敏感。如果靶向这种无反应的基质,去势的效果可以增强。

相似文献

1
A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.一种基质靶向疗法可增强可移植大鼠前列腺癌模型中的去势效果。
Prostate. 2007 Nov 1;67(15):1664-76. doi: 10.1002/pros.20657.
2
Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).用雄激素去除与Trk酪氨酸激酶抑制剂CEP-751(KT-6587)或CEP-701(KT-5555)联合治疗的Dunning H大鼠前列腺癌在体内持续消退。
Cancer Res. 1999 May 15;59(10):2395-401.
3
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.去势治疗数月后,核雄激素受体在恶性和非恶性人类前列腺组织的上皮和基质成分中再次出现。
Prostate. 2007 Sep 1;67(12):1277-84. doi: 10.1002/pros.20569.
4
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.正常和肿瘤前列腺组织中低基质雄激素受体水平与前列腺癌患者的不良预后相关。
Prostate. 2009 Jun 1;69(8):799-809. doi: 10.1002/pros.20927.
5
Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels.去势诱导的人前列腺组织上皮细胞死亡与局部胰岛素样生长因子-1水平降低有关。
Prostate. 2007 Jan 1;67(1):32-40. doi: 10.1002/pros.20480.
6
Androgen and prostatic stroma.雄激素与前列腺基质。
Asian J Androl. 2003 Mar;5(1):19-26.
7
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.卡比多巴增强比卡鲁胺对去势抵抗性前列腺肿瘤雄激素受体轴的抗肿瘤活性。
Prostate. 2012 Jun 1;72(8):875-85. doi: 10.1002/pros.21490. Epub 2011 Oct 5.
8
Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.去势诱导大鼠腹侧前列腺细胞凋亡,但对雄激素敏感的前列腺腺癌细胞无此作用。
Cancer Res. 1994 Jul 1;54(13):3594-601.
9
Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.去势及雌激素处理后大鼠腹侧前列腺和Dunning R3327 PAP前列腺肿瘤中转化生长因子-β1的表达
Prostate. 1996 Oct;29(4):209-18. doi: 10.1002/(SICI)1097-0045(199610)29:4<209::AID-PROS2>3.0.CO;2-6.
10
Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.将小鼠前列腺自发性转基因腺癌(TRAMP)作为研究去势治疗效果的模型进行特征描述。
Prostate. 2005 Feb 1;62(2):148-64. doi: 10.1002/pros.20123.

引用本文的文献

1
Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.基于三维图像的力学建模用于预测乳腺癌对新辅助治疗的反应
Comput Methods Appl Mech Eng. 2017 Feb 1;314:494-512. doi: 10.1016/j.cma.2016.08.024. Epub 2016 Sep 1.
2
Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype.大鼠前列腺肿瘤细胞在骨微环境中进展为高度侵袭性表型。
Neoplasia. 2016 Mar;18(3):152-61. doi: 10.1016/j.neo.2016.01.007.
3
Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.
在去势治疗后,临床晚期前列腺癌中基质变化的强度与肿瘤复发相关。
Asian J Androl. 2014 Sep-Oct;16(5):710-4. doi: 10.4103/1008-682X.129131.
4
The stroma-a key regulator in prostate function and malignancy.基质——前列腺功能和恶性肿瘤的关键调节因子。
Cancers (Basel). 2012 May 29;4(2):531-48. doi: 10.3390/cancers4020531.
5
Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.年轻男性和老年男性前列腺基质细胞中表达的雄激素受体在前列腺癌进展中表现出相反的作用。
Asian J Androl. 2013 Sep;15(5):672-8. doi: 10.1038/aja.2013.45. Epub 2013 Jun 24.
6
Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.上皮细胞 Hic-5/ARA55 的表达有助于前列腺肿瘤的发生和去势反应。
Oncogene. 2011 Jan 13;30(2):167-77. doi: 10.1038/onc.2010.400. Epub 2010 Sep 6.
7
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.肥大细胞是前列腺癌中新型的独立预后标志物,是治疗的靶点。
Am J Pathol. 2010 Aug;177(2):1031-41. doi: 10.2353/ajpath.2010.100070. Epub 2010 Jul 8.
8
Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.前列腺肿瘤和非恶性前列腺组织中的基质 PDGFRβ表达可预测前列腺癌的生存。
PLoS One. 2010 May 20;5(5):e10747. doi: 10.1371/journal.pone.0010747.
9
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.一种新型雄激素受体剪接变体在前列腺癌进展过程中上调,并促进抗雄激素耗竭的生长。
Cancer Res. 2009 Mar 15;69(6):2305-13. doi: 10.1158/0008-5472.CAN-08-3795. Epub 2009 Feb 24.
10
Stroma-epithelium crosstalk in prostate cancer.前列腺癌中的基质-上皮细胞相互作用
Asian J Androl. 2009 Jan;11(1):28-35. doi: 10.1038/aja.2008.39. Epub 2008 Dec 22.